Beyond the Basics: A Deep Dive into Bone Marrow Transplant (BMT) and Cell Therapy (CT)

Exclusive to Stanford Health Care & Stanford Children's Health (LPCH) Employees

This class is full.  Please click here to be placed on the waiting list.  When a space becomes available, you will be notified via email.

Calling all experienced inpatient and outpatient BMT/CT nurses!

This course comprehensively examines the latest bone marrow transplants and cell therapy advancements. During this class, you will hear from world-class providers who will help equip you with the knowledge to provide exceptional patient care. Why is this relevant? BMT and CT have revolutionized patient care for various conditions, from hematologic malignancies to autoimmune disorders. Nurses play a pivotal role in this rapidly growing field. By attending this course, you'll be able to describe the rationale for different types of cell therapies used to treat noncancerous diseases and new indications for cell therapies. You will also gain a deeper understanding into how new BMT and CT therapies work and their outcomes. Lastly, you will be able to recall different approaches to discussing end of life care with patients and providers and how implicit bias can affect these discussions. Are you ready to elevate your expertise and provide exceptional care for BMT and CT patients? Join us for this engaging and informative course! Register now as space is extremely limited! Participants are required to attend 100% of the course and complete the evaluation to obtain a CE certificate.

1. Describe the rationale for different types of cell therapies used to treat noncancerous diseases and new indications for use
2. Recall different approaches to discussing end-of-life care with patients and providers and how implicit bias can affect these discussions.
3. Understand how new BMT and CT treatments work and their outcomes

Fees: $100.00

Please be sure to pay with a credit card, if payment is not received, your registration will be incomplete and you will not be registered for the course.

Note: If the Registration button is no longer visible, the class is full and no longer accepting registrations. No wait list available.

Cancellation Fee:
$35.00 for cancellations received less than 14 days from the course date.  
NO REFUND for no shows or cancellations received within 48 hours from the course date.

1. Stanford Health Care is provider approved by the California Board of Registered Nursing (BRN).  Provider Number CEP12165.
2. Stanford Health Care Center for Education and Professional Development is accredited as a provider of nursing continuing professional development by the American Nurses Credentialing Center’s Commission on Accreditation.
*Neither SHC nor ANCC endorse any commercial products

©2024 by Stanford Health Care, Division of Patient Care Services.
All rights reserved. No audio or video taping allowed. We reserve the right to make program changes. All students must be registered, attend the entire course, and submit an evaluation after course completion to earn credit hours.

Mitigation of Relevant Financial Relationships

Stanford Health Care (SHC) adheres to the ACCME’s Standards for Integrity and Independence in Accredited Continuing Education. Any individuals in a position to control the content of a CE activity, including faculty, planners, reviewers or others are required to disclose all relevant financial relationships with ineligible entities (commercial interests). All relevant financial relationships have been mitigated prior to the commencement of the activity.

Member Information

Role in activity

Nature of Relationship(s) / Name of Ineligible Company(s)

Theresa Latchford, MS
Stanford Health Care

Content Expert

Speakers Bureau-Bristol-Myers Squibb (Relationship has ended)|Speakers Bureau-Gilead

Diana Mazur, MSN
Stanford Health Care

Content Expert

Nothing to disclose

Allison Betof Warner, MD
Stanford University

Faculty

Consulting Fee-Adaptimmune|Consulting Fee-Bristol-Myers Squibb (Relationship has ended)|Consulting Fee-Genmab (Relationship has ended)|Consulting Fee-Immatics (Relationship has ended)|Consulting Fee-IO Biotech (Relationship has ended)|Consulting Fee-Iovance Biotherapeutics (Relationship has ended)|Consulting Fee-Novartis AG (Relationship has ended)|Consulting Fee-Merck and Company, Inc.|Consulting Fee-Pfizer, Inc. (Relationship has ended)|Consulting Fee-Replimune (Relationship has ended)|Grant or research support-Bristol-Myers Squibb|Grant or research support-Iovance Biotherapeutics (Relationship has ended)|Grant or research support-Lyell Immunopharma|Grant or research support-Obsidian Therapeutics

Saurabh Dahiya, MD

Faculty

Advisor-Gilead (Relationship has ended)

Everett Meyer, MD
Stanford University

Faculty

Grant or research support-Orca Biosystems|Grant or research support-Kyverna

Marissa Miller, physician assistant
Stanford Health Care

Faculty

Nothing to disclose

Andrew R Rezvani, MD
Stanford University

Faculty

Grant or research support-Gamida (Relationship has ended)

Melody Smith, MD
Stanford University

Faculty

Membership on Advisory Committees or Review Panels, Board Membership, etc.-CVS Caremark|Advisor-A28 Therapeutics

Emily S Ranieri, MSN
Stanford Health Care

Faculty, Nurse Planner (CEPD Staff Only)

Nothing to disclose

Karen Kalaw, MSN
Stanford Health Care

Other Planning Committee Member

Nothing to disclose

Tuesday, October 29, 2024